Researchers at JRBiomedical, based in Cardiff, have devised a novel, affordable 10-minute test for detecting sepsis and severe infections.

Uncovered Molecule: sTLR2 (Soluble Toll-like Receptor 2) by the Research Team

, and Administrator

2025 September 15 . 1:06 AM

1 min read

Affordable, swift 10-minute diagnosis test for sepsis and severe infections devised by... — Affordable, swift 10-minute diagnosis test for sepsis and severe infections devised by Cardiff-based researchers at JRBiomedical

Researchers at JRBiomedical, based in Cardiff, have devised a novel, affordable 10-minute test for detecting sepsis and severe infections.

A new diagnostic center has been launched in Kuvempunagar, Mysuru, Karnataka. Agilus Diagnostics, in collaboration with the Karnataka CDC, has opened this state-of-the-art facility, led by Dr. Sushma. The new diagnostic center does not appear to be focused on any specific disease or condition.

Meanwhile, the World Health Organization (WHO) has made an update to its Essential Medicines List (EML). The EML now includes rapid-acting insulin analogues and GLP-1 receptor agonists. However, the reason for this update remains unclear.

Elsewhere, Dr. Lal PathLabs has adopted an AI module in its cancer diagnosis processes. The details of how this AI module has been integrated into their existing processes remain undisclosed.

In another development, ShardaCare Healthcity and Sharda Hospital have appointed Sandeep Dogra as their Group COO. No further details about this appointment were provided.

Finally, the Department for Promotion of Industry and Internal Trade (DPIIT) has signed an MoU with Pfizer. The specifics of this MoU were not disclosed.

It should be noted that no new information about the AI module in cancer diagnosis, the role of robotics in kidney-preserving cancer care, or any other specific announcements or statements were provided in relation to Agilus Diagnostics, Karnataka CDC, Dr. Lal PathLabs, or any other entities mentioned in this article.